Yves Beguin

Nocardia Infections in Hematopoietic Cell Transplant Recipients: A Multicenter International Retrospective Study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation

D. Lebeaux, M. Aljurf, O. Lortholary, 2021 .

Preemptive cellular immunotherapy after T-cell-depleted allogeneic hematopoietic stem cell transplantation.

Y. Beguin, F. Baron, Yves Beguin, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Oral minocycline as systemic therapy for uncomplicated venous access device-related bloodstream infection with coagulase-negative staphylococci after allogeneic hematopoietic cell transplantation.

M. Hayette, S. Servais, F. Frippiat, 2023, Current research in translational medicine.

MINITRANSPLANTS: ALLOGENEIC STEM CELL TRANSPLANTATION WITH REDUCED TOXICITY

Y. Beguin, F. Baron, Yves Beguin, 2003, Acta clinica Belgica.

Adoptive immunotherapy with donor lymphocyte infusionsafter allogeneic HPC transplantation

Y. Beguin, F. Baron, Yves Beguin, 2000, Transfusion.

Graft-versus-Host Disease Prophylaxis with Post Transplant Cyclophosphamide in Chronic Myeloid Leukemia patients undergoing Allogeneic Hematopoietic Cell Transplant from either an Unrelated or Mismatched Related Donor: a comparative study from the Chr....

I. Yakoub-Agha, D. Mclornan, L. Griškevičius, 2023, Transplantation and cellular therapy.

Elevations of tumor necrosis factor receptor 1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

F. Baron, L. Seidel, Y. Beguin, 2010, Bone Marrow Transplantation.